Unity Biotechnology Stock Forecast, Price & News

Unity Biotechnology (NASDAQ:UBX) Frequently Asked Questions

Is Unity Biotechnology a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Unity Biotechnology in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Unity Biotechnology stock.
View analyst ratings for Unity Biotechnology or view top-rated stocks.

How has Unity Biotechnology's stock price been impacted by COVID-19?

Unity Biotechnology's stock was trading at $5.39 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, UBX stock has decreased by 78.5% and is now trading at $1.16.
View which stocks have been most impacted by COVID-19.

Are investors shorting Unity Biotechnology?

Unity Biotechnology saw a drop in short interest in December. As of December 31st, there was short interest totaling 721,600 shares, a drop of 22.0% from the December 15th total of 925,100 shares. Based on an average trading volume of 1,100,000 shares, the days-to-cover ratio is presently 0.7 days. Currently, 1.9% of the company's stock are short sold.
View Unity Biotechnology's Short Interest.

When is Unity Biotechnology's next earnings date?

Unity Biotechnology is scheduled to release its next quarterly earnings announcement on Tuesday, March 22nd 2022.
View our earnings forecast for Unity Biotechnology.

How were Unity Biotechnology's earnings last quarter?

Unity Biotechnology, Inc. (NASDAQ:UBX) released its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.30) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.36) by $0.06.
View Unity Biotechnology's earnings history.

What price target have analysts set for UBX?

5 brokerages have issued 1 year price targets for Unity Biotechnology's stock. Their forecasts range from $4.00 to $12.00. On average, they expect Unity Biotechnology's stock price to reach $6.60 in the next year. This suggests a possible upside of 469.0% from the stock's current price.
View analysts' price targets for Unity Biotechnology or view top-rated stocks among Wall Street analysts.

Who are Unity Biotechnology's key executives?

Unity Biotechnology's management team includes the following people:

• Anirvan Ghosh, Chief Executive Officer & Director
• Nathan Guz, Vice President-Operations
• Lynne Sullivan, Chief Financial Officer
• Jamie Dananberg, Chief Medical Officer
• Susan Lundeen Smuck, Chief Human Resources Officer

Who are some of Unity Biotechnology's key competitors?

Some companies that are related to Unity Biotechnology include APM Human Services International (APM), Asian Citrus (ACHL), CUE Energy Resources (CUE), Graphene NanoChem (GRPH), Inova Resources Limited, (IVA), Mawson Infrastructure Group (MIGID) and Panther Metals (PNT).
View all of UBX's competitors.

What other stocks do shareholders of Unity Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Unity Biotechnology investors own include NIO (NIO), Inseego (INSG), NVIDIA (NVDA), Editas Medicine (EDIT), Advanced Micro Devices (AMD), (CGC), VBI Vaccines (VBIV), Enphase Energy (ENPH), Sorrento Therapeutics (SRNE) and OPKO Health (OPK).

When did Unity Biotechnology IPO?

(UBX) raised $85 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 5,000,000 shares at $16.00-$18.00 per share. Goldman Sachs, Morgan Stanley and Citigroup served as the underwriters for the IPO and Mizuho Securities was co-manager.

What is Unity Biotechnology's stock symbol?

Unity Biotechnology trades on the NASDAQ under the ticker symbol "UBX."

How do I buy shares of Unity Biotechnology?

Shares of UBX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Unity Biotechnology's stock price today?

One share of UBX stock can currently be purchased for approximately $1.16.

How much money does Unity Biotechnology make?

Unity Biotechnology has a market capitalization of $66.96 million.

How many employees does Unity Biotechnology have?

Unity Biotechnology employs 70 workers across the globe.

What is Unity Biotechnology's official website?

The official website for Unity Biotechnology is www.unitybiotechnology.com.

How can I contact Unity Biotechnology?

The company can be reached via phone at (650) 416-1192.